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Background. Although Schistosoma haematobium infection has been reported to be associated with alterations in immune 
function, in particular immune hyporesponsiveness, there have been only few studies that have used the approach of removing in-
fection by drug treatment to establish this and to understand the underlying molecular mechanisms.
Methods. Schistosoma haematobium-infected schoolchildren were studied before and after praziquantel treatment and com-
pared with uninfected controls. Cellular responses were characterized by cytokine production and flow cytometry, and in a subset of 
children RNA sequencing (RNA-Seq) transcriptome profiling was performed. 
Results. Removal of S haematobium infection resulted in increased schistosome-specific cytokine responses that were negatively 
associated with CD4+CD25+FOXP3+ T-cells and accompanied by increased frequency of effector memory T-cells. Innate responses 
to Toll like receptor (TLR) ligation decreased with treatment and showed positive association with CD4+CD25+FOXP3+ T-cells. At 
the transcriptome level, schistosome infection was associated with enrichment in cell adhesion, whereas parasite removal was as-
sociated with a more quiescent profile. Further analysis indicated that alteration in cellular energy metabolism was associated with 
S haematobium infection and that the early growth response genes 2 and 3 (EGR 2 and EGR3), transcription factors that negatively 
regulate T-cell activation, may play a role in adaptive immune hyporesponsiveness. 
Conclusions. Using a longitudinal study design, we found contrasting effects of schistosome infection on innate and adaptive 
immune responses. Whereas the innate immune system appears more activated, the adaptive immunity is in a hyporesponsive state 
reflected in alterations in CD4+CD25+FOXP3+ T-cells, cellular metabolism, and transcription factors involved in anergy.
Keywords.  CD4+CD25+FOXP3+ T-cells; cytokines; praziquantel; Schistosoma haematobium; transcriptome profiling.
Schistosomiasis, caused by parasitic trematodes of the genus 
Schistosoma, affects more than 200 million people world-
wide, especially children [1]. Chronic infections with schis-
tosomes are associated with immune hyporesponsiveness 
characterized by reduced in vitro proliferation of T lympho-
cytes and decreased cytokine production in response to not only 
schistosomal antigens [2] but also to third-party antigens such 
as Mycobacterium tuberculosis purified protein derivative [3, 4]. 
Treatment with the antischistosomal drug praziquantel (PZQ) 
leads to clearance of infection [5], elevated antigen-specific pro-
liferation [6], and cytokine production [7, 8]. The mechanisms 
of T-cell hyporesponsiveness during chronic schistosomiasis 
are not well understood, but several recent reports have shown 
that in addition to impaired dendritic cell (DC) activity during 
schistosome infection [9], regulatory T-cells (Tregs) [10] and 
regulatory B cells [11] are expanded in schistosome-infected 
compared with uninfected individuals. However, few studies 
have examined the effect that parasite elimination by chemo-
therapy has on CD4+CD25+FOXP3+ T-cells and how this is 
linked to innate and adaptive immune responses.
Regarding the innate immune system, responses to and ex-
pression levels of the Toll-like receptors (TLRs) have been 
shown to be altered in Schistosoma haematobium-infected in-
dividuals [9, 12, 13]. Most of these data come from studies that 
were cross-sectional in design. Questions remain about whether 
Summary
We report results of immune and transcriptome profiling of longitudinal samples from S haematobium-infected schoolchildren from rural Gabon who were treated with praziquantel and unin-
fected controls who informed the study of background longitudinal changes unrelated to treatment.
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the removal of schistosome infection with chemotherapy affects 
innate immune responses and whether there is any link to reg-
ulatory responses.
Because immunity against schistosome infection is highly 
complex and dynamic, pattern-based approaches such as global 
gene expression profiling could be ideal to further our under-
standing of mechanisms associated with immune modulation. 
There are no studies that have examined changes caused by 
transcriptional signatures of human peripheral blood after ef-
fective antischistosomiasis treatment that might give a broader 
view on and better understanding of how schistosomes affect 
the immune system. There are also no studies that have simul-
taneously analyzed immune and transcriptome profiles during 
infection and treatment.
In the present study, we report the results of immune and 
transcriptome profiling of a set of longitudinal samples from 
S haematobium-infected subjects from rural Gabon who were 
treated with PZQ and uninfected controls who could inform the 
study of background longitudinal changes not related to treatment.
MATERIALS AND METHODS
Ethics Statement
The study was approved by “Comité d’Ethique Régional 
Indépendant de Lambaréné” (No. 06/08). Written informed 
consent was obtained from parents or legal guardians of all 
participants.
Study Population and Parasitology
Between November 2008 and February 2009 (baseline) and June 
and December 2009 (follow-up), 79 S haematobium-infected 
schoolchildren and uninfected controls were recruited for im-
munological profiling, and an additional 17 were recruited for 
transcriptome profiling from a S haematobium-endemic rural 
area surrounding Lambaréné (Gabon) [13].
Schistosoma haematobium infection was determined at base-
line and follow-up before blood collection by examining a 
10-mL filtrate of urine passed through a 12-µm pore size filter 
(Millipore); children were classified S haematobium-infected if 
at least 1 S haematobium egg was detected or uninfected if 3 
consecutive samples were negative. Infections with intestinal 
helminths Ascaris lumbricoides, Trichuris trichiura, and hook-
worm were determined in 1 fresh stool sample using Kato-
Katz at baseline only. Infection with Plasmodium falciparum 
was determined by polymerase chain reaction (PCR) with a 
cutoff value of 35 cycle threshold (Ct). After blood collection, 
all S haematobium-infected children were treated 3 times with 
single-dose PZQ (40  mg/kg) at 2-month intervals. Intestinal 
helminth- and malaria-infected children received single-
dose albendazole (400 mg) or artemisinin-based combination 
therapy, respectively, as per national guidelines.
Hematological parameters were analyzed using ADVIA 
120 Hematology System (Bayer Health Care), and 
erythrocyte sedimentation rate (ESR) was determined man-
ually. Circulating anodic antigen (CAA) levels were deter-
mined using upconverting phosphor (UCP) technology 
lateral flow assay [14]. Reagent strips (Cobas) were used to 
assess hematuria, leukocyturia, and proteinuria, and their 
scores, ranging from 0 to 3, were added together to calculate 
the combined reagent strip index (RSI).
Whole Blood Culture
Five hours after venipuncture, heparinized blood was diluted 
2× with RPMI-1640  (Invitrogen) supplemented with 100 U/
mL penicillin (Astellas), 10 µg/mL streptomycin, 1 mM pyru-
vate, and 2 mM L-glutamine (all from Sigma-Aldrich). To as-
sess innate responses, whole blood was incubated for 24 hours 
with 100  ng/mL Pam3CSK-SKKKK (EMC Microcollection). 
To assess adaptive responses, whole blood was incubated for 72 
hours with S haematobium soluble egg antigen (SEA) or adult 
worm antigen (AWA) (both 10 µg/mL) or 2 µg/mL phytohaem-
agglutinin ([PHA] Remel). Medium without stimulus was used 
as negative control. One hundred microliters of ligand(s) in 
medium was added to wells containing 100  µL diluted blood 
in 96-well round bottom plates (Nunc) and incubated at 37°C 
in the presence of 5% CO2. Supernatants were stored at −80°C.
Cytokine Analysis
Supernatants were analyzed simultaneously for interleukin (IL)-10, 
IL-1β, and tumor necrosis factor (TNF) or IFN-γ, IL-2, IL-5, IL-10, 
and TNF using customized Luminex cytokine kits (Invitrogen) 
according to manufacturers’ recommendations. Samples were 
acquired with Luminex-100 cytometer (Luminex Corporation). 
Samples below detection limit were assigned values corresponding 
to half of lowest value detected. For interferon (IFN)-γ, IL-2, IL-5, 
IL-10, and TNF multiplex assay, lowest values detected were .090 
pg/mL for IFN-γ, .063 pg/mL for IL-2, .044 pg/mL for IL-5, .063 
pg/mL for IL-10, and .051 pg/mL for TNF. For IL-10, IL-1β, and 
TNF multiplex assay, lowest values detected were .016 pg/mL for 
IL-10, .255 pg/mL for IL-1β, and .016 pg/mL for TNF.
Memory and CD4+CD25+FOXP3+ T-Cell Immunophenotyping
Peripheral blood mononuclear cells (PBMCs) were isolated by 
density centrifugation on Ficoll (AZL pharmacy). For memory 
T-cell immunophenotyping, PBMCs were fixed in 2.4% form-
aldehyde (Sigma-Aldrich), frozen in RPMI 1640 medium sup-
plemented with 20% fetal bovine serum (Greiner Bio-One) 
and 10% dimethyl sulfoxide (Merck), and stored at −80°C. 
After thawing, cells were stained with anti-CD4-PE-Cy7 (RPA-
T4; eBioscience), anti-CD45RA-Horizon V450 (HI100; BD 
Biosciences), and anti-CD27-FITC (L128; BD Biosciences). For 
CD4+CD25+FOXP3+ T-cell immunophenotyping, PBMCs were 
fixed with FoxP3 fixation/permeabilization kit (eBisocience) 
and stored at −80°C. After thawing, cells were stained with 
CD4-PE-Cy7 (SK3; BD Biosciences), CD25-PE (2A3; BD 
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Biosciences), and FOXP3-APC (PCH101; eBioscience). 
Cells were acquired on FACSCanto II flow cytometer (BD 
Biosciences) and analyzed in FlowJo software version 9 (Tree 
Star Inc.); boolean gates were used for memory T-cell analysis.
Statistical Analysis
Differences between study groups for gender, malaria, and in-
testinal helminth infections were tested using Fisher’s exact 
test. Differences in malaria prevalence pre- to posttreatment 
were tested with McNemar’s test. Age, ESR, and hemogram 
parameters were tested using independent t test. Infection in-
dices and T-cell subsets were compared with Mann-Whitney U 
test. Within group differences between baseline and follow-up 
were compared with Wilcoxon matched-pairs test. Correlations 
between infection indices were analyzed by Spearman’s rank 
correlation.
Stimulated cytokine concentrations were corrected for spon-
taneous cytokine production by subtracting responses of un-
stimulated medium wells, with negatives values set to half of 
the lowest value detected per given cytokine, and normalized by 
log (base 10) transformation after adding 1 pg/mL. Univariate 
general linear model analysis adjusted for age was used to com-
pare between infection groups, and resulting adjusted means 
were antilog-transformed for graphing purposes. Differences 
within the same group between baseline and follow-up were 
compared by paired t test.
Repeated-measures, linear mixed-effects model was used 
to assess the following: longitudinal association between 
CD4+CD25+FOXP3+ T-cell levels and cytokine responses to 
Pam3 and schistosomal products with cytokine levels as de-
pendent variable; participant identification as random effect; 
infection group as fixed effect; and CD4+CD25+FOXP3+ T-cell 
level as covariate.
For all tests, statistical significance was considered at the 5% 
level. To adjust for multiple comparisons, Bonferroni-Holm 
correction was used. Data were analyzed using IBM SPSS 
Statistics (IBM Corp.).
Ribonucleic Acid (RNA) Isolation and Illumina Sequencing
Ribonucleic acid was extracted from PBMCs and stored in total 
RNA Lysis solution (Invitrogen) at −80°C. Messenger RNA 
(mRNA) was purified using ABI PRISM 6100 Nucleic Acid 
PrepStation (Applied Biosystems) according to manufacturer’s 
recommendations. Samples were treated with DNAse, integ-
rity of each RNA preparation was verified on 2100 Bioanalyzer 
(Agilent), and concentration was assessed on a Qubit fluorom-
eter (Thermo Fisher Scientific). Poly(A) RNA was selected from 
1 µg total RNA using Dynabeads mRNA Direct Micro kit (Life 
Technologies) and reverse transcribed using Ovation RNA 
Amplification System V2 (NuGEN Technologies). Multiplexed, 
paired-end, small fragment, Illumina libraries were con-
structed with Kapa LTP Library Prep kit (Kapa Biosystems) 
and sequenced on Illumina HiSeq 2000 version 3 flow cell ac-
cording to manufacturer’s recommendations (Illumina Inc). All 
gene expression data are publically available (National Center 
for Biotechnology Information [NCBI]’s Gene Expression 
Omnibus; Series Accession Numbers GSE92917 [GSM2440-
348/349/350/351/352/353/354/355/356/357/358/359/360/361] 
and GSE113287 [GSM3102-791/792/793/794/797/798/801/802/ 
803/804/805/806/807/808/811/812/813/814/815/816]).
Bioinformatics Analyses
Paired-end reads were mapped to human genome reference as-
sembly GRCh37-lite with Ensembl 74 annotation (NCBI) using 
TopHat, which incorporates the Bowtie v2.1.0 algorithm [15]. 
Resultant TopHat mappings were processed through Cufflinks 
into transcripts [16], and raw digital read counts were made 
using HTSeq [17]. Differential expression analysis between S 
haematobium-infected and uninfected controls and between 
baseline and follow-up within each group was performed by 
edgeR likelihood ratio test [18] after normalization by RUVseq 
[19] applying false discovery rate (FDR) significance cutoff of 
≤.05. Gene ontology analysis was performed using WebGestalt 
[20]. The FDR control (Benjamini and Hochberg method) was 
used to correct for multiple testing. GSEAPreranked module, 
with scoring scheme parameter set to classic, was used to con-
duct gene set enrichment analysis [21] of blood transcription 
modules (BTMs) [22] and KEGG metabolic pathways. Data 
were analyzed in R version 3.6.1 and visualized using pheatmap 
and ggplot2 packages.
RESULTS
Study Population Characteristics
Study subjects for immunological profiling comprised S 
haematobium-infected schoolchildren (N = 40) and uninfected 
controls (N = 39). There were no significant differences be-
tween the groups in P falciparum, A lumbricoides, T trichiura, 
and hookworm prevalence or in hematological parameters at 
baseline (Supplementary Table 1). Schistosome infection as as-
sessed by egg counts, plasma CAA, hematuria, and RSI score 
are given in Table 1; as expected, all were significantly correl-
ated (P < .001). Praziquantel treatment significantly reduced 
all parameters in infected schoolchildren (P < .001) (Table 1). 
A subset of study subjects comprising S haematobium-infected 
schoolchildren (N = 8) and uninfected controls (N = 9) was 
profiled transcriptionally. This group showed no demographic, 
parasitological, or hematological differences (P > .05; data not 
shown) from subjects included in immunological profiling.
Antischistosome Treatment Decreases Tumor Necrosis Factor (TNF) Levels 
in Response to Toll-Like Receptor (TLR) Stimulation
Over the 7-month study period, TNF response to Pam3 de-
creased significantly in infected subjects who successfully 
cleared infection (Figure  1) but not in uninfected controls. 
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Levels of IL-1β and IL-10 decreased significantly in all study 
subjects, which may be related to longitudinal seasonal or envi-
ronmental changes. No differences were observed in cytokine 
production of unstimulated cells between infection groups or 
between baseline and follow-up time points (Supplementary 
Figure 1A).
Reversal of Antigen-Specific Hyporesponsiveness After Antischistosome 
Treatment Is Accompanied by an Increase in Effector T-Cells
At baseline, S haematobium-infected schoolchildren responded 
to SEA and AWA, by producing IFN-γ, IL-2, IL-5, IL-10, 
and TNF, whereas uninfected controls did not (Figure  2 and 
Supplementary Table 2A). There were no differences in response 
to PHA between infected and uninfected controls at baseline. 
Cytokine responses to SEA and AWA increased after treat-
ment (Figure  2 and Supplementary Table 2B), as did IL-10 in 
response to PHA (P = .001). No differences were seen in sponta-
neous cytokine production (in unstimulated cultures) between 
infected and uninfected children or between baseline and fol-
low-up (Supplementary Figure 1B). Increased adaptive immune 
responses after PZQ treatment were accompanied by increased 
frequency of effector memory T-cells ([TEM] CD45RA
−CD27−) 
(Figure 3B).
Association Between CD4+CD25+FOXP3+ T-Cells and Innate and Adaptive 
Cytokine Responses
Percentage of CD4+CD25+FOXP3+ T-cells was found to be signif-
icantly higher in infected children at baseline and was significantly 
reduced, to levels comparable to uninfected controls, after treat-
ment (Figure  4). Longitudinal decrease in CD4+CD25+FOXP3+ 
T-cell frequencies was parallel with a similar decrease observed 
in TNF levels in response to Pam3 (estimate β = 1.04; 95% con-
fidence interval [CI], 0.10–1.97; P < .05) (Supplementary Table 
3). In contrast, there was a negative association between longitu-
dinal decrease in CD4+CD25+FOXP3+ T-cell frequencies and an 
increase in adaptive cytokine responses, and this reached statis-
tical significance for IL-5 and IL-10 in response to both SEA and 
AWA and for IL-2 in response to AWA (estimate β = −1.04 [95% 
CI = −1.91 to −0.18], estimate β = −1.08 [95% CI = −1.76 to −0.41], 
estimate β = −1.15 [95% CI = −1.69 to −0.62], estimate β = −0.60 
[95% CI = −1.02 to −0.18], and estimate β = −0.47 [95% CI = −0.94 
to .00], respectively; all P < .05) (Supplementary Table 3).
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Figure 1. Cytokine production in response to Toll-like receptor (TLR)2/1 stimulation in whole blood cultures. Whole blood from Schistosoma haematobium (S.h.)-infected 
schoolchildren and uninfected controls was stimulated with Pam3 (TLR2/1). After 24 hours of culture, tumor necrosis factor ([TNF] A), interleukin (IL)-1β (B), and IL-10 (C) 
were measured by Luminex. Differences between groups were tested with general linear model univariate analysis adjusted for age and within groups with a paired sample 
t test. Results are shown as age-adjusted geometric means. **, P < .01; ***, P < .001. Numbers of donors in each group: S.h. (−) baseline n = 39, S.h. (−) follow-up n = 39, 
S.h. (+) baseline n = 40, and S.h. (+) follow-up n = 40.
Table 1. Median Values of Infection Indices in Study Populationa
Infection Indices
Baseline Follow-up
Schistosoma haematobium  
Uninfected
S haematobium  
Infected
S haematobium  
Uninfected
S haematobium  
Infected
Median egg counts (IQR) 0.0 (0.0–.0)b 19.5 (5.3–87.0)b,c 0.0 (0.0–.0) 0.0 (0.0–.0)c
Plasma CAA levels pg/mL (IQR) 0.0 (0.0–3.0)b 420.5 (12.3–1196.3)b,c 0.0 (0.0–.3) 12.5 (0.0–74.3)c
Hematuria score (IQR) 0.0 (0.0–.0)b 3.0 (0.0–3.0)b,c 0.0 (0.0–.0) 0.0 (0.0–.0)c
RSI score (IQR) 0.0 (0.0–2.0)b 5.0 2.0–6.3)b,c 0.0 (0.0–2.0) 0.0 (0.0–1.0)c
Abbreviations: CAA, circulating anodic antigen; IQR, interquartile range; RSI, reagent strip index.
aDifferences between groups were tested with Mann-Whitney U test and within group differences between baseline and follow-up with Wilcoxon matched pairs test. Significant between 
group differences are indicated with b and within group differences with c; all P < .001. Infection indices were all significantly correlated with each other: egg counts with hematuria (ρ = .767, 
P < .001); egg counts with RSI (ρ = .746, P < .001); CAA with hematuria (ρ = .632, P < .001); CAA with RSI (ρ = .556, P < .001); and egg counts with CAA (ρ = .748, P < .001).
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Schistosoma haematobium Infection and Treatment Are Associated With 
Distinct Transcriptional Profiles
Schistosoma haematobium infection was associated with al-
tered expression of 320 genes (140 upregulated and 180 
downregulated) compared with uninfected controls, whereas 
after PZQ treatment, only 4 genes were differentially ex-
pressed between the 2 groups. Praziquantel treatment was as-
sociated with altered expression of 192 genes (34 upregulated 
and 158 downregulated), whereas 4 genes were differentially 
expressed over the same time period in the control group 
(Figure 5A). Results obtained for all 11 112 genes are provided 
in online Supplementary Table 4, and clustering of the top 50 
most significant genes at baseline and after PZQ treatment 
are shown in Figure 5B. Gene ontology analysis emphasized 
enrichment in processes associated with cell adhesion during 
infection, whereas PZQ treatment resulted in downregulation 
of immune responses and cell cycle (Supplementary Table 5). 
Blood transcription module (BTM) analysis based on gene 
networks specific for blood immune responses identified 
positive enrichment at baseline in S haematobium-infected 
individuals for T-cells and mitotic cell cycle and reduced 
gene signatures for natural killer (NK) cells, DCs, and mono-
cytes. Treatment reversed differences in NK cell signatures 
and mitotic cell cycle, and further differences were observed 
in reduced overall immune activation, whereas T-cell acti-
vation further increased (Figure 6 and Supplementary Table 
6). Finally, targeted analysis of KEGG metabolic pathways 
using GSEA revealed upregulation in “oxidative phosphoryl-
ation” and the “citrate/TCA cycle” in schistosome-infected 
subjects. After PZQ treatment, oxidative phosphorylation 
was further upregulated, whereas the citrate/TCA cycle was 
downregulated (Figure 6 and Supplementary Table 6).
DISCUSSION
Downregulation of immune responses has been ascribed to 
a strong immunomodulatory network induced by schisto-
somes. In this study, we show that not only (as shown earlier) 
CD4+CD25+FOXP3+ T-cell numbers decrease after PZQ 
treatment [10, 23], but we link this to the reversal of T-cell 
hyporesponsivness. Of note, changes in cell subset levels may 
also be reflected in the RNA-seq data where elevated levels 
of mitotic cell cycle and cell division BTMs were observed 
during infection and were downregulated after PZQ treat-
ment. CD4+CD25+FOXP3+ T-cells seem to have the ability to 
control effector T-cell responses as suggested by the observa-
tion of a parallel increase in  effector memory (TEM) cells and 
an increase in adaptive cytokine production after PZQ treat-
ment of infected children. Interestingly we found that the crit-
ical transcriptional factors for the induction of T-cell anergy, 
the early growth response genes 2 and 3 (EGR2 and EGR3), 
are significantly downregulated after treatment (Egr2 and Egr3 
are zinc-finger transcription factors of the Egr family and both 
have been shown to be involved in the induction and mainte-
nance of T-cell anergy [24]). These data indicate that in addi-
tion to regulation by Tregs, there may also be anergy-related 
hyporesponsiveness. In a recent study, Fasciola hepatica infec-
tion was reported to be associated with enhanced expression of 
EGR2 [25]. Egr2 and/or Egr3 directly induce expression of sup-
pressor of cytokine signaling (SOCS)1 and SOCS3, inhibitors 
of STAT1 and STAT3 [26]; a significant decrease in SOCS3 was 
observed in our dataset after treatment, mirroring the decrease 
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Figure 2. Cytokine production in response to schistosomal antigens in whole 
blood cultures. Whole blood from Schistosoma haematobium-infected schoolchil-
dren and uninfected controls was stimulated with schistosomal egg antigen (SEA) 
and adult worm antigen (AWA). After 72 hours of culture, levels of Th1 (A), Th2 (B), 
regulatory (C), proinflammatory (D), and interleukin (IL)-2 (E) cytokines were meas-
ured by Luminex. The follow-up samples were obtained at 7 months posttreatment 
with praziquantel (PZQ) of children that were infected with S haematobium at pre-
treatment. The uninfected controls were also examined at the same follow-up period 
but did not receive PZQ. At baseline, S haematobium (S.h.)-infected schoolchildren 
responded to SEA and AWA by producing cytokines, whereas uninfected controls 
did not (all P < .01 except for interferon [IFN]-γ [P = .145] and tumor necrosis factor 
[TNF] [P = .034] in response to SEA). For baseline/follow-up comparison, **P < .01, 
and ***P < .001. Numbers of donors in each group: S.h. (−) baseline n = 39, S.h. (−) 
follow-up n = 39, S.h. (+) baseline n = 40, and S.h. (+) follow-up n = 40.
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Figure 3. Memory T-cell (TCM) analysis. CD4
+ T-cells were identified, and Boolean gating combinations were used to determine proportions of T-cell subsets based 
on CD45RA and CD27 expression (A). Proportion of CD4+-gated cells that were CD45RA−CD27+ (TCM), CD45RA
+CD27+ (naive), CD45RA−CD27− (memory T-cells [TEM]), and 
CD45RA+CD27− (TEMRA) were determined for Schistosoma haematobium (S.h.)-infected and -uninfected controls at baseline and follow-up (B). Differences between groups 
were tested with general linear model univariate analysis adjusted for age and within groups with a paired sample t test. Results are shown as unadjusted values. Horizontal 
bars represent median. *, P < .05. Numbers of donors in each group: S.h. (−) baseline n = 28, S.h. (−) follow-up n = 27, S.h. (+) baseline n = 31, and S.h. (+) follow-up n = 28. 
FSC, forward scatter; SSC, side scatter.
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Figure 4. CD4+CD25+FOXP3+ T-cell analysis. CD4+CD25+FOXP3+ T-cells were identified and enumerated in a subset of participants with flow cytometry with initial gating 
steps performed as described in Figure 3 (A), and frequencies were determined for Schistosoma haematobium (S.h.)-infected children and uninfected controls at baseline 
and at follow-up (B). Differences between groups were tested with general linear model univariate analysis adjusted for age and within groups with a paired sample t test. 
Results are shown as unadjusted values. Horizontal bars represent median. *, P < .05; **, P < .01. Numbers of donors in each group: S.h. (−) baseline n = 7, S.h. (−) 6-week 
follow-up n = 7, S.h. (−) 7-month follow-up n = 6, S.h. (+) baseline n = 10, S.h. (+) 6-week follow-up n = 10, and S.h. (+) 7-month follow-up n = 7.
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in both EGR2 and EGR3. Further studies will be needed to as-
sess the role of EGR2 and EGR3 in specific cell subsets during 
schistosomiasis.
At the cytokine level, baseline adaptive cytokine responses 
of whole blood samples from S haematobium-infected 
schoolchildren responded to SEA and AWA stimula-
tion, whereas uninfected controls did not, indicating pres-
ence of antigen-specific memory T-cells during infection. 
Chemotherapy over a 7-month period resulted in increased 
adaptive cytokine production. Enhanced cytokine responses 
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Figure 5. Differentially expressed genes during Schistosoma haematobium infection. Volcano plot displaying differentially expressed genes (false discovery rate [FDR]-
adjusted, P < .05) between S haematobium-infected schoolchildren and uninfected controls and within each group between baseline and follow-up (A). Heatmaps of 
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posttreatment have been seen in a number of short-term, 5- to 
7-week posttreatment studies [6–8, 23, 27]. A study examining 
immune responses 1 and 2  years posttreatment of Kenyan 
Schistosoma mansoni-infected schoolchildren observed an 
increase in Th2 responses (IL-4, IL-5, IL-9, and IL-13) to both 
SEA and AWA; however, proinflammatory responses (IL-1β, 
TNF, CCL5, and IL-6) were decreased in response to SEA or un-
changed in response to AWA [28]. It is interesting to speculate 
that the decrease in IL-1β, TNF, CCL5, and IL-6 in the Kenyan 
cohort may represent an innate immune component and may 
be in line with our results in which a significant decrease in in-
nate TNF response was observed posttreatment. In contrast to 
the Kenyan cohort, we did not see a decrease in TNF response 
to SEA. However, it should be noted that children recruited 
in the Kenyan study all presented with hepatomegaly and ex-
hibited predominant proinflammatory responses at pretreat-
ment, whereas children in our study were free of pathology 
as assessed by bladder ultrasonography (AAA,  unpublished 
data, 2008–2009). Our study indicates that parasite removal 
over a longer period of time in children without pathology is 
associated with sustained enhancement of antigen-specific re-
sponses, in agreement with short-term treatment studies and 
the increase in Th2 responses seen in the long-term treatment 
Kenyan study [28].
The observation of a significant decrease in TNF levels in re-
sponse to TLR stimulation in vitro in the infected group treated 
with PZQ is in line with findings that show TNF to be associated 
with schistosomiasis [13, 29, 30]. It is interesting to note that there 
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was a significant association between the decrease in TNF response 
to Pam3 and the decrease in CD4+CD25+FOXP3+ T-cells. This is 
in line with several studies in murine models that show TNF [31] 
and signaling through TNF receptor II to be important for Tregs 
[31–33], whereas limited human studies have shown contrasting re-
sults [34–37]. The possibility that such differences might be due to 
involvement of different regulatory T-cell subsets would need to be 
considered because studies in murine models have shown that nat-
ural Tregs (nTregs) but not inducible Tregs (iTregs) require TNF-α 
for their in vivo function [38], and human studies have shown that 
anti-TNF-α antibody significantly reduces Helios+ Treg prolifera-
tion but increases proliferation of Helios− Tregs [36].
Helminth infections induce inflammation resulting in the 
mobilization, proliferation, and recruitment of immune cells. 
Although microarray studies have shown an upregulation 
of cell migration and chemokines in the liver of Schistosoma 
japonicum-infected mice [39, 40], our RNA-seq data suggest a 
previously underappreciated enrichment of cell adhesion in pe-
ripheral blood during infection. In addition, a number of top 
genes differentially expressed during infection or PZQ treat-
ment were chemokine and chemokine receptor genes. It is inter-
esting to note that a study on P falciparum and S haematobium 
coinfection showed that S haematobium infection was associ-
ated with an increased chemokine profile [41].
Recent research has shown that a number of abnormal 
and atypical immune responses result from incorrect met-
abolic activity and that manipulation of cellular metabo-
lism can augment and moderate immunity [42]. Metabolic 
processes including oxidative phosphorylation, glycolysis, 
and lipid and fatty acid metabolism have highly specific 
effects on immune cell function [42]. Analysis of classic 
metabolic pathways showed that citrate/TCA cycle and oxi-
dative phosphorylation were both significantly upregulated 
during schistosome infection. Recent reports have high-
lighted the role of these pathways in induction and main-
tenance of type 2 immunity [43] typically associated with 
schistosomiasis, and future studies will be needed to ex-
plore the relationship between immunometabolism and 
immune responses during schistosomiasis in endemic 
populations. Intriguingly, EGR2 was recently shown to play 
a role in immune metabolism and to be upstream of lipid 
metabolism genes [44].
Finally, BTM analysis suggests a role for NK cells during S 
haematobium infection. Natural killer cells have been shown 
to be activated during helminth infection [45, 46], and in vivo 
depletion of NK cells in a murine model of filarial infection 
strongly enhanced worm load and influenced IL-4 and IL-5 
plasma levels [47]. In addition, although their activity is sig-
nificantly depressed in chronically S mansoni-infected patients 
[48], the role of these cells in protective responses during hel-
minth infection is still not clear and warrants further analysis.
CONCLUSIONS
In summary, this study not only compared S haematobium-
infected and -uninfected subjects at baseline, but it also com-
pared subjects whose infection was removed by PZQ treatment, 
to pinpoint the responses specifically affected by schistosome 
infection. Our results show that infection with S haematobium 
is associated with antigen-specific hyporesponsiveness, al-
terations of the T-cell memory pool, and increased levels of 
CD4+CD25+FOXP3+ T-cells and that PZQ treatment leads to 
increased effector T-cell frequencies and decreased levels of 
CD4+CD25+FOXP3+ T-cells, which were associated with de-
creased TLR-specific TNF levels and increased antigen-specific 
cytokine production. Parallel transcriptome interrogation in-
dicates that in addition to regulation by Tregs, there is also 
hyporesponsiveness due to anergy, and it suggests a previously 
underappreciated enrichment for immune cell adhesion in pe-
ripheral blood and a role of immunometabolism and NK cells 
in the course of S haematobium infection.
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